Abstract

Those with a complete set of samples – blood, fresh tissue and paraffin embedded tissue together with a robust set of clinical data and clinical follow up and outcome information
1) Insecure funding, and the necessity to continuously apply for ongoing funding 2) Collection of long-term (5 years plus) clinical follow-up data once patients have been discharged from their treating physicians
Obtain high-density genomic and proteomic data on a subset of donors and make these data available to researchers
